USD 159.81
(1.21%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.72 USD | 55.0% |
2022 | -1.60 USD | -3.9% |
2021 | -1.54 USD | 29.68% |
2020 | -2.19 USD | -56.43% |
2019 | -1.40 USD | 6.67% |
2018 | -1.50 USD | -15.38% |
2017 | -1.30 USD | 12.75% |
2016 | -1.49 USD | 12.87% |
2015 | -1.71 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.34 USD | -168.0% |
2024 Q2 | 0.33 USD | 197.06% |
2024 Q3 | 0.62 USD | 87.88% |
2023 FY | - USD | 55.0% |
2023 Q3 | -0.29 USD | 29.27% |
2023 Q2 | -0.41 USD | 22.64% |
2023 Q1 | -0.53 USD | -581.82% |
2023 Q4 | 0.50 USD | 272.41% |
2022 Q4 | 0.11 USD | 118.33% |
2022 Q2 | -0.53 USD | 13.11% |
2022 Q1 | -0.61 USD | -598.74% |
2022 FY | - USD | -3.9% |
2022 Q3 | -0.60 USD | -13.21% |
2021 Q3 | -0.38 USD | 20.83% |
2021 FY | - USD | 29.68% |
2021 Q1 | -0.60 USD | -114.29% |
2021 Q2 | -0.48 USD | 20.0% |
2021 Q4 | -0.09 USD | 77.03% |
2020 FY | - USD | -56.43% |
2020 Q1 | -0.67 USD | -76.32% |
2020 Q2 | -0.88 USD | -31.34% |
2020 Q3 | -0.39 USD | 55.68% |
2020 Q4 | -0.28 USD | 28.21% |
2019 Q3 | -0.34 USD | -6.25% |
2019 FY | - USD | 6.67% |
2019 Q1 | -0.35 USD | -59.09% |
2019 Q4 | -0.38 USD | -11.76% |
2019 Q2 | -0.32 USD | 8.57% |
2018 Q1 | -0.48 USD | -41.18% |
2018 Q2 | -0.43 USD | 10.42% |
2018 Q3 | -0.22 USD | 48.84% |
2018 Q4 | -0.22 USD | 0.0% |
2018 FY | - USD | -15.38% |
2017 Q1 | -0.36 USD | 0.0% |
2017 FY | - USD | 12.75% |
2017 Q2 | -0.38 USD | -5.56% |
2017 Q3 | -0.32 USD | 15.79% |
2017 Q4 | -0.34 USD | -6.25% |
2016 FY | - USD | 12.87% |
2015 FY | - USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Abbott Laboratories | 3.30 USD | 121.818% |
Allurion Technologies Inc. | -2.31 USD | 68.831% |
Artivion, Inc. | -0.75 USD | 4.0% |
Avanos Medical, Inc. | -1.33 USD | 45.865% |
Butterfly Network, Inc. | -0.65 USD | -10.769% |
Butterfly Network, Inc. | -0.65 USD | -10.769% |
Bio-Rad Laboratories, Inc. | -21.82 USD | 96.7% |
Boston Scientific Corporation | 1.08 USD | 166.667% |
CONMED Corporation | 2.10 USD | 134.286% |
Edwards Lifesciences Corporation | 2.31 USD | 131.169% |
Paragon 28, Inc. | -0.58 USD | -24.138% |
Glaukos Corporation | -2.78 USD | 74.101% |
Globus Medical, Inc. | 1.09 USD | 166.055% |
Integer Holdings Corporation | 2.72 USD | 126.471% |
Medtronic plc | 2.77 USD | 125.993% |
Myomo, Inc. | -0.28 USD | -157.143% |
Nevro Corp. | -2.56 USD | 71.875% |
Owlet, Inc. | -4.53 USD | 84.106% |
Penumbra, Inc. | 2.37 USD | 130.38% |
Vicarious Surgical Inc. | -0.49 USD | -46.939% |
Smith & Nephew plc | 0.60 USD | 220.0% |
STERIS plc | 3.83 USD | 118.799% |
Stryker Corporation | 8.34 USD | 108.633% |
Vapotherm, Inc. | -9.64 USD | 92.531% |
Zimmer Biomet Holdings, Inc. | 4.91 USD | 114.664% |